Zirconium Dioxide Fixed Dental Prosthesis.
Monolithic- and Partially Veneered High-translucent Zirconium Dioxide (YSZ), a 4-year Follow-up of a Multicenter Prospective, Randomized Controlled Trial on Posterior FDPs.
1 other identifier
interventional
31
1 country
2
Brief Summary
The purpose of this clinical trial is to evaluate and compare bridges to replace one or two missing teeth in the mouth. The bridges will be made of two variants of ceramic material. We will evaluate the bridges for up to five years regarding technical and biological complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2017
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2023
CompletedFirst Submitted
Initial submission to the registry
March 20, 2024
CompletedFirst Posted
Study publicly available on registry
April 8, 2024
CompletedNovember 26, 2025
November 1, 2025
1.8 years
March 20, 2024
November 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Fractures
Minor or major fractures of the fixed dental prosthesis material
4 years; From cementation of the fixed dental prosthesis up to the final evaluation.
De-bonding
Loss of retention of the fixed dental prosthesis.
4 years; From cementation of the fixed dental prosthesis up to the final evaluation.
Secondary Outcomes (4)
Caries
4 years; From cementation of the fixed dental prosthesis to the final evaluation.
Endodontic
4 years; From cementation of the fixed dental prosthesis to the final evaluation.
Function
4 years; From cementation of the fixed dental prosthesis to the final evaluation.
Esthetics
4 years. From cementation of the fixed dental prosthesis to the final evaluation.
Study Arms (2)
Veneered high-translucent zirconium dioxide fixed dental prosthesis
EXPERIMENTALCore material: high translucent zirconium dioxide (BruxZir, Glidewell, Newport Beach, Canada) Buccal veneer: porcelain (GC initial Zr, GC Corporation, Tokyo, Japan).
Monolithic high-translucent zirconium dioxide fixed dental prosthesis
ACTIVE COMPARATORHigh translucent zirconium dioxide (BruxZir, Glidewell, Newport Beach, Canada)
Interventions
Fixed dentals prosthesis made out of high translucent zirconium dioxide with or without a porcelain veneer.
Eligibility Criteria
You may qualify if:
- Patients who needed an FDP replacing one or two missing teeth in the posterior dentition (premolars and/or molars).
You may not qualify if:
- High caries activity Active periodontal disease Previously known history of repeated fractures of filings and/or reconstructions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Malmö Universitylead
Study Sites (2)
Malmo university
Malmo, Skåne County, 214 21, Sweden
Malmo university
Malmo, Skåne County, 21421, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emma Gardell
Malmo university
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Both participant, care providers, dental technicians and the investigator are blinded in the process.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 20, 2024
First Posted
April 8, 2024
Study Start
December 20, 2017
Primary Completion
September 27, 2019
Study Completion
January 20, 2023
Last Updated
November 26, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
The study began enrolling patients before January 1 2019.